Travere Therapeutics
Agent39Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Trust89Data Trust: 89/100. Top 25%. Measured by StartupHub.ai. Median 61.A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
Travere Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing transformative therapies for patients with rare diseases and conditions with high unmet medical need. The company's lead product candidate, pegtaralgene (CHTR-001), is in development for the treatment of nephropathic cystinosis.
Listed competitors
Biopharmaceutical company developing transformative medicines for patients with genetic diseases and cancers.
Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
Global leader in animal health, providing innovative products and services for pets and livestock.
Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
A commercial-stage biopharmaceutical company developing cell and gene therapies for rare diseases.
Biotechnology company focused on developing treatments for rare metabolic diseases.
Japanese biopharmaceutical company developing biologics and gene therapies for CNS and rare diseases.
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
Ultiracer is an indoor cycling platform developed by RealDesignTech that offers brain-body balance training through real steering, weight shifting, and balance control, enhancing cognitive performance and fitness.
Global biopharmaceutical company specializing in plasma-derived therapeutics for rare and serious conditions.
Key facts
- Website
- travere.com
- Headquarters
- San Diego, California, USA
- Founded
- 2015
- Employees
- 125
- Business model
- B2B
Tech stack
Detected on travere.com, last scanned 21 Oct 2026. Run your own scan
- Frontend
- jQuery, Tailwind CSS
- Analytics
- Google Tag Manager, LinkedIn Insight Tag
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Mimecast
- Cookie consent
- OneTrust
Travere Therapeutics scores 58. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
What does Travere Therapeutics do?
Travere also has a pipeline of other rare disease programs.
Is Travere Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Travere Therapeutics is 89 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does Travere Therapeutics have?
Travere Therapeutics has approximately 125 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Travere Therapeutics
